Immunohistochemistry (IHC)
Olig2 Methodology Immunohistochemistry (IHC) Test Description Olig2, a transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors,…
Cytogenetics
Oncology Chromosome Analysis Alternative Name Oncology Cytogenetics, Oncology Karyotyping Methodology Cytogenetics Test Description Cytogenetic analysis can provide an…
Immunohistochemistry (IHC)
p120 Catenin Methodology Immunohistochemistry (IHC) Test Description P120 Catenin is a tyrosine kinase which binds to E-cadherin within the cell membrane. It is detectable in the cell membranes of a…
Immunohistochemistry (IHC)
p16 Methodology Immunohistochemistry (IHC) Test Description p16 (p16 -INK4a, p16-MTS1, inhibitor of CDK4) is the product of the CDKN2 gene. It inhibits the progression of the cell cycle through the G1…
Immunohistochemistry (IHC)
p40 Methodology Immunohistochemistry (IHC) Test Description p40 antibody recognizes ΔNp63—a p63 isoform. It is equivalent to p63 in sensitivity for squamous cell carcinoma, but it is markedly superior…
Immunohistochemistry (IHC)
P501S Methodology Immunohistochemistry (IHC) Test Description P501S protein, also called the prostein, is a type IIIa plasma membrane protein which is exclusively expressed in cells of normal and…
Immunohistochemistry (IHC)
P504S Methodology Immunohistochemistry (IHC) Test Description Expression of P504S protein, or Alpha-methylacyl-CoA Racemase (AMACR), is found in prostatic adenocarcinoma but not in benign prostatic…
Immunohistochemistry (IHC)
p53 Methodology Immunohistochemistry (IHC) Test Description The product of the p53 gene is a nuclear phosphoprotein that regulates cell proliferation. Excess accumulation of the mutant p53 gene…
Immunohistochemistry (IHC)
p57 Methodology Immunohistochemistry (IHC) Test Description p57 (Kip 2, CDKN 1C) is an inhibitor of several G1 cyclin complexes and is a negative regulator of cell proliferation. The gene encoding…
Immunohistochemistry (IHC)
p63 Methodology Immunohistochemistry (IHC) Test Description p63 is a homologue of the p53 gene and is necessary for normal breast and prostate development. Unlike other markers of myoepithelial cells…
Immunohistochemistry (IHC)
pAKT (Phosphorylated AKT) Methodology Immunohistochemistry (IHC) Test Description AKT is a signal transduction protein that plays a central role in inhibiting apoptosis in a variety of tumor types.…
Immunohistochemistry (IHC)
Pan-Cytokeratin Alternative Name CK AE1/AE3 Methodology Immunohistochemistry (IHC) Test Description Monoclonal antibodies AE1 and AE3 recognize the acidic and basic…
Immunohistochemistry (IHC)
Pan-TRK Alternative Name TRKA, TRKB, TRKC Methodology Immunohistochemistry (IHC) Test Description Pan-TRK (clone EPR17341) is directed against the C-terminal region…
Immunohistochemistry (IHC)
Parafibromin Methodology Immunohistochemistry (IHC) Test Description Complete absence of nuclear staining for parafibromin is diagnostic of parathyroid carcinoma or an HPT-JT-related tumor (…
Immunohistochemistry (IHC)
Parvovirus Methodology Immunohistochemistry (IHC) Test Description This monoclonal antibody clone, R92F6, recognizes a capsid protein of human parvovirus B19. Therefore, this antibody will be useful…
Immunohistochemistry (IHC)
PAX2 Methodology Immunohistochemistry (IHC) Test Description Paired Box 2 (PAX2) is a transcription factor that is essential for kidney development. In kidneys of normal adult, Pax2 protein expression…
Immunohistochemistry (IHC)
PAX8 Methodology Immunohistochemistry (IHC) Test Description The PAX8 gene is a member of the paired box (PAX) family of transcription factors. This family plays critical roles during fetal…
FISH
PDGFRA Amplification Alternative Name PDGFR Alpha Amplification Methodology FISH Test Description Probes: PDGFRA (4q12) | Centromere 4 Disease(s): Brain cancer…
Molecular
PDGFRa Mutation Analysis Alternative Name PDGFR Alpha Mutation Analysis Methodology Molecular Test Description Bi-directional sequencing of exons 12 and 18 of the…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA for NSCLC Alternative Name Formerly named PD-L1 22C3 FDA (KEYTRUDA®) for NSCLC Methodology Immunohistochemistry (IHC) Test Description PD-L1 IHC 22C3…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for Cervical Methodology Immunohistochemistry (IHC) Test Description PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1,…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for ESCC (Esophageal Squamous Cell Carcinoma) Methodology Immunohistochemistry (IHC) Test Description PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for Gastric/GEA Alternative Name PD-L1, 22C3 FDA (KEYTRUDA®) for Gastric/GEA Methodology Immunohistochemistry (IHC) Test Description PD-L1…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck) Alternative Name PD-L1, 22C3, KEYTRUDA Methodology Immunohistochemistry (IHC) Test Description PD-L1 IHC 22C3…
Immunohistochemistry (IHC)
PD-L1 22C3 FDA (KEYTRUDA®) for TNBC (Breast) Methodology Immunohistochemistry (IHC) Test Description PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1…